IL5320-1mg

LXW7， a cyclic peptide containing Arg-Gly-Asp (RGD)， is an integrin αvβ3 inhibitor with a high binding affinity for αvβ3 integrin， enhancing VEGFR-2 phosphorylation and ERK1/2 activation.